175 related articles for article (PubMed ID: 37702484)
1. Alteration in gut mycobiota of patients with polycystic ovary syndrome.
Chen K; Geng H; Liu J; Ye C
Microbiol Spectr; 2023 Sep; 11(5):e0236023. PubMed ID: 37702484
[TBL] [Abstract][Full Text] [Related]
2. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
4. Metagenomic-based characterization of the gut virome in patients with polycystic ovary syndrome.
Huang L; Wu X; Guo S; Lv Y; Zhou P; Huang G; Duan Z; Sun W
Front Microbiol; 2022; 13():951782. PubMed ID: 36051758
[TBL] [Abstract][Full Text] [Related]
5. Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota.
Zhang F; Ma T; Tong X; Liu Y; Cui P; Xu X; Shi J; Hu W; Lu W; Pei Z; Xu M; Li X; Xu C; Feng Y
Acupunct Med; 2022 Aug; 40(4):347-359. PubMed ID: 34892981
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
7. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
[No Abstract] [Full Text] [Related]
9. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.
Li G; Liu Z; Ren F; Shi H; Zhao Q; Song Y; Fan X; Ma X; Qin G
Front Microbiol; 2022; 13():911992. PubMed ID: 35847083
[TBL] [Abstract][Full Text] [Related]
10. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
Rizk MG; Thackray VG
J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome.
Yang Z; Fu H; Su H; Cai X; Wang Y; Hong Y; Hu J; Xie Z; Wang X
Front Microbiol; 2022; 13():1017147. PubMed ID: 36338055
[TBL] [Abstract][Full Text] [Related]
12. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
Front Physiol; 2022; 13():887077. PubMed ID: 35800349
[No Abstract] [Full Text] [Related]
13. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome.
Lin W; Wen L; Wen J; Xiang G
Front Endocrinol (Lausanne); 2021; 12():747888. PubMed ID: 34858330
[TBL] [Abstract][Full Text] [Related]
14. Characteristic gut microbiota and predicted metabolic functions in women with PCOS.
Zhou L; Ni Z; Cheng W; Yu J; Sun S; Zhai D; Yu C; Cai Z
Endocr Connect; 2020 Jan; 9(1):63-73. PubMed ID: 31972546
[TBL] [Abstract][Full Text] [Related]
15. Impact of Visceral Obesity on Structural and Functional Alterations of Gut Microbiota in Polycystic Ovary Syndrome (PCOS): A Pilot Study Using Metagenomic Analysis.
Bai X; Ma J; Wu X; Qiu L; Huang R; Zhang H; Huang H; Chen X
Diabetes Metab Syndr Obes; 2023; 16():1-14. PubMed ID: 36760592
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome.
Qi X; Yun C; Sun L; Xia J; Wu Q; Wang Y; Wang L; Zhang Y; Liang X; Wang L; Gonzalez FJ; Patterson AD; Liu H; Mu L; Zhou Z; Zhao Y; Li R; Liu P; Zhong C; Pang Y; Jiang C; Qiao J
Nat Med; 2019 Aug; 25(8):1225-1233. PubMed ID: 31332392
[TBL] [Abstract][Full Text] [Related]
18. The gut microbial composition in polycystic ovary syndrome with hyperandrogenemia and its association with steroid hormones.
Li M; Chang Q; Luo Y; Pan J; Hu Y; Liu B; Ma M; Wang Q; Guo Y; Wang Q
Front Cell Dev Biol; 2024; 12():1384233. PubMed ID: 38872933
[No Abstract] [Full Text] [Related]
19. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
20. The Salivary Microbiome in Polycystic Ovary Syndrome (PCOS) and Its Association with Disease-Related Parameters: A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Pieber TR; Gorkiewicz G; Obermayer-Pietsch B
Front Microbiol; 2016; 7():1270. PubMed ID: 27610099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
